Publication:
BRCA1 Haploinsufficiency Is Masked by RNF168-Mediated Chromatin Ubiquitylation.

dc.contributor.authorZong, Dali
dc.contributor.authorAdam, Salomé
dc.contributor.authorWang, Yifan
dc.contributor.authorSasanuma, Hiroyuki
dc.contributor.authorCallén, Elsa
dc.contributor.authorMurga, Matilde
dc.contributor.authorDay, Amanda
dc.contributor.authorKruhlak, Michael J
dc.contributor.authorWong, Nancy
dc.contributor.authorMunro, Meagan
dc.contributor.authorRay Chaudhuri, Arnab
dc.contributor.authorKarim, Baktiar
dc.contributor.authorXia, Bing
dc.contributor.authorTakeda, Shunichi
dc.contributor.authorJohnson, Neil
dc.contributor.authorDurocher, Daniel
dc.contributor.authorNussenzweig, André
dc.contributor.funderMinisterio de Educación, Cultura y Deporte (España)
dc.contributor.funderUnited States Department of Health and Human Services
dc.contributor.funderLawrence Ellison Foundationes_ES
dc.contributor.funderUnited States Department of Defense
dc.contributor.funderAlex's Lemonade Stand Foundationes_ES
dc.contributor.funderNIH - National Cancer Institute (NCI) (Estados Unidos)
dc.contributor.funderRutgers Cancer Institutees_ES
dc.date.accessioned2024-02-09T11:34:00Z
dc.date.available2024-02-09T11:34:00Z
dc.date.issued2019-03-21
dc.description.abstractBRCA1 functions at two distinct steps during homologous recombination (HR). Initially, it promotes DNA end resection, and subsequently it recruits the PALB2 and BRCA2 mediator complex, which stabilizes RAD51-DNA nucleoprotein filaments. Loss of 53BP1 rescues the HR defect in BRCA1-deficient cells by increasing resection, suggesting that BRCA1's downstream role in RAD51 loading is dispensable when 53BP1 is absent. Here we show that the E3 ubiquitin ligase RNF168, in addition to its canonical role in inhibiting end resection, acts in a redundant manner with BRCA1 to load PALB2 onto damaged DNA. Loss of RNF168 negates the synthetic rescue of BRCA1 deficiency by 53BP1 deletion, and it predisposes BRCA1 heterozygous mice to cancer. BRCA1+/-RNF168-/- cells lack RAD51 foci and are hypersensitive to PARP inhibitor, whereas forced targeting of PALB2 to DNA breaks in mutant cells circumvents BRCA1 haploinsufficiency. Inhibiting the chromatin ubiquitin pathway may, therefore, be a synthetic lethality strategy for BRCA1-deficient cancers.es_ES
dc.description.peerreviewedes_ES
dc.description.sponsorshipWe thank Sergio Ruiz Macias, Avinash Bhandoola, Haico van Attikum, Niels Mailand, and Nussenzweig lab members for stimulating discussions; Yaakov Maman and Sriram Sridharan for help with statistical analysis; Richard Baer and Thomas Ludwig for BRCA1+/Delta 2 mice; and Jennifer Wise, Kelly Smith, Raymond Hui, and Breana Myers for assistance with animal work. M. Murga was funded by a grant from the Salvador Madariaga Program (PRX18/00364) from the Spanish Ministry of Education, Culture and Sports, within the framework of the National Program of Talent Promotion and its usefulness in R&D&I, National Mobility Subprogram, National Plan of R&D&I. The A.N. laboratory is supported by the Intramural Research Program of the NIH, an Ellison Medical Foundation Senior Scholar in Aging Award (AG-SS-2633-11), the Department of Defense Idea Expansion (W81XWH-15-2-006) and Breakthrough (W81XWH-16-1-599) Awards, the Alex Lemonade Stand Foundation Award, and an NIH Intramural FLEX Award. The work was also supported by the Rutgers Cancer Institute and the NCI-CCR Partnership on DNA Repair and Genomic Instability in Cancer.es_ES
dc.format.number6es_ES
dc.format.page1267es_ES
dc.format.volume73es_ES
dc.identifier.citationMol Cell . 2019 ;73(6):1267-1281.es_ES
dc.identifier.doi10.1016/j.molcel.2018.12.010es_ES
dc.identifier.e-issn1097-4164es_ES
dc.identifier.journalMolecular celles_ES
dc.identifier.pubmedID30704900es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/17692
dc.language.isoenges_ES
dc.publisherCell Press
dc.relation.publisherversionhttps://doi.org/10.1016/j.molcel.2018.12.010es_ES
dc.repisalud.institucionCNIOes_ES
dc.repisalud.orgCNIOCNIO::Grupos de investigación::Grupo de Inestabilidad Genómicaes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subject.meshHaploinsufficiencyes_ES
dc.subject.meshUbiquitinationes_ES
dc.subject.meshAnimalses_ES
dc.subject.meshBRCA1 Proteines_ES
dc.subject.meshBRCA2 Proteines_ES
dc.subject.meshCell Line, Tumores_ES
dc.subject.meshChromatines_ES
dc.subject.meshDNA Damagees_ES
dc.subject.meshFanconi Anemia Complementation Group N Proteines_ES
dc.subject.meshFemalees_ES
dc.subject.meshFibroblastses_ES
dc.subject.meshMicees_ES
dc.subject.meshMice, Inbred C57BLes_ES
dc.subject.meshMice, Knockoutes_ES
dc.subject.meshMutationes_ES
dc.subject.meshNeoplasmses_ES
dc.subject.meshPoly(ADP-ribose) Polymerase Inhibitorses_ES
dc.subject.meshRad51 Recombinasees_ES
dc.subject.meshRecombinational DNA Repaires_ES
dc.subject.meshTumor Suppressor p53-Binding Protein 1es_ES
dc.subject.meshUbiquitin-Protein Ligaseses_ES
dc.titleBRCA1 Haploinsufficiency Is Masked by RNF168-Mediated Chromatin Ubiquitylation.es_ES
dc.typejournal articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublication109ab297-8df3-458e-9a03-0dd210ea8e09
relation.isAuthorOfPublication.latestForDiscovery109ab297-8df3-458e-9a03-0dd210ea8e09
relation.isFunderOfPublication41383d53-27b2-4b36-a8d4-ead2ae8fe63b
relation.isFunderOfPublication6081a0d0-d423-4510-b1af-a52eac0c92e4
relation.isFunderOfPublication8b5eb01a-f061-4bf4-8399-c5812208bb3b
relation.isFunderOfPublicationb589134c-ce3e-4f64-a3f5-83d0a7eb706a
relation.isFunderOfPublication.latestForDiscovery41383d53-27b2-4b36-a8d4-ead2ae8fe63b
relation.isPublisherOfPublicationaea619d1-42a6-47f8-84e2-6bc27d6f8300
relation.isPublisherOfPublication.latestForDiscoveryaea619d1-42a6-47f8-84e2-6bc27d6f8300

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
brca1haploinsufficiency_2019.pdf
Size:
3.58 MB
Format:
Adobe Portable Document Format
Description:
Artículo principal